| Drug Type Small molecule drug | 
| Synonyms- | 
| Target- | 
| Action- | 
| Mechanism- | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date Japan (14 Nov 2020),  | 
| Regulation- | 
| Molecular FormulaClNa | 
| InChIKeyFAPWRFPIFSIZLT-UHFFFAOYSA-M | 
| CAS Registry7647-14-5 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Intracranial Hypertension | Japan  | 14 Nov 2020 | |
| Ocular Hypertension | Japan  | 14 Nov 2020 | 





